Y-Intercept (HK)’s GenMark Diagnostics, Inc GNMK Stock Holding History

Y-Intercept (HK)’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,409	Closed	-$166K	–	892
2020 Q4	$166K	Buy	+11,409	New	+$151K	0.07%	465

Other funds holding GNMK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Y-Intercept (HK)'s GNMK Position: Q1 2021 in Review

Y-Intercept (HK) sold out of GenMark Diagnostics, Inc (GNMK) in Q1 2021, closing a stake of 11,409 shares — an estimated $166K sold.

Y-Intercept (HK) first reported a position in GNMK in Q4 2020 and held it in 1 quarter. The position peaked at $166K in Q4 2020. 164 funds tracked by Wall St. Rank hold GNMK as of Q1 2021.

Y-Intercept (HK) reported no remaining GenMark Diagnostics, Inc position as of Q1 2021 after selling out during the quarter.
Y-Intercept (HK) sold 11,409 GenMark Diagnostics, Inc shares in Q1 2021, an estimated $166K.
Y-Intercept (HK) first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 1 quarter.
Y-Intercept (HK)'s GenMark Diagnostics, Inc position peaked at $166K in Q4 2020.
164 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q1 2021.

Based on Y-Intercept (HK)'s 13F filing for Q1 2021, filed 12 May 2021.